How significant is sidelining Dr. Bright to developing a vaccine?

Dr. Eric Feigl-Ding, epidemiologist and Harvard public health scientist, joins us to discuss how safe the anti-malaria drug hydroxychloroquine is and the outcome for patients who have used it.